Drug intelligence / Profile preview

Yuyangsan enema II

Development stage: Unknown
Lead developer: Jiangsu Provincial Hospital of Traditional Chinese Medicine
Administration: Rectal

Overview

Yuyangsan enema II is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Nanjing Hospital of Traditional Chinese Medicine. It is designed for the treatment of active ulcerative colitis, particularly in patients diagnosed with the damp-heat in the large intestine pattern according to TCM theory. Administered rectally as an enema, the drug is intended to reduce colonic inflammation and promote mucosal healing. It is currently being evaluated in clinical trials as an adjunctive therapy to standard-of-care mesalamine to improve clinical outcomes in patients with mild to moderate disease.

Other names: Yuyangsan ulcerated enema IIYuyangsan Enema II

Beyond the preview

Go deeper on Yuyangsan enema II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yuyangsan enema II.

Explore the full profile